Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -12.40% is 46% above its 5-year average of -23.03%, near the high end of its 5-year range (-94.66%–14.33%).
58.88% above its 12-month average of -30.15%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.14%.
NET PROFIT MARGIN
-12.40%
NET PROFIT MARGIN AVG TTM
-30.15%
NET PROFIT MARGIN AVG 3Y
-24.45%
NET PROFIT MARGIN AVG 5Y
-23.03%
NET PROFIT MARGIN AVG 10Y
-16.20%
NET PROFIT MARGIN AVG 15Y
-29.77%
NET PROFIT MARGIN AVG 20Y
-42.15%
CURRENT VS TTM AVG
+58.88%
CURRENT VS 3Y AVG
+49.29%
CURRENT VS 5Y AVG
+46.17%
CURRENT VS 10Y AVG
+23.47%
CURRENT VS 15Y AVG
+58.34%
CURRENT VS 20Y AVG
+70.58%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-4669.23%
vs the sector median at left
OPKO Health, Inc.
Market Cap
$1.10B
Net Profit Margin
-12.40%
TTM Avg
-30.15%
3Y Avg
-24.45%
5Y Avg
-23.03%
Market Cap
$1.10B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.10B
Net Profit Margin
-6.08%
TTM Avg
-15.19%
3Y Avg
-17.99%
5Y Avg
-12.77%
Market Cap
$1.10B
Net Profit Margin
1.13%
TTM Avg
-33.60%
3Y Avg
-11.14%
5Y Avg
-1.51%
Market Cap
$1.09B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.08B
Net Profit Margin
26.70%
TTM Avg
26.54%
3Y Avg
25.84%
5Y Avg
21.67%
Market Cap
$1.12B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.08B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.13B
Net Profit Margin
10.76%
TTM Avg
17.71%
3Y Avg
18.77%
5Y Avg
14.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OPKO Health, Inc. (OPK) | $1.10B | -12.40% | -30.15% | -24.45% | -23.03% |
| Replimune Group, Inc. (REPL)vs › | $1.10B | 0.00% | 0.00% | 0.00% | 0.00% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.10B | -6.08% | -15.19% | -17.99% | -12.77% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 1.13% | -33.60% | -11.14% | -1.51% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.09B | 0.00% | 0.00% | 0.00% | 0.00% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 26.70% | 26.54% | 25.84% | 21.67% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.12B | 0.00% | 0.00% | 0.00% | 0.00% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.08B | 0.00% | 0.00% | 0.00% | 0.00% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.13B | 10.76% | 17.71% | 18.77% | 14.94% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | -13.51% | -5.33% | -11.32% | -12.84% |
Operating Margin
-36.1%
Net Profit Margin
-12.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -5.14% |
| 2026-03-31 | -44.16% |
| 2025-12-31 | -21.06% |
| 2025-09-30 | 14.26% |
| 2025-06-30 | -94.66% |
| 2025-03-31 | -45.09% |
| 2024-12-31 | 7.64% |
| 2024-09-30 | 14.33% |
| 2024-06-30 | -5.66% |
| 2024-03-31 | -47.12% |
| 2023-12-31 | -36.55% |
| 2023-09-30 | -47.30% |
| 2023-06-30 | -7.40% |
| 2023-03-31 | -7.69% |
| 2022-12-31 | -45.99% |
| 2022-09-30 | -47.90% |
| 2022-06-30 | -32.80% |
| 2022-03-31 | -16.84% |
| 2021-12-31 | -18.38% |
| 2021-09-30 | 7.45% |
| 2021-06-30 | -3.66% |
| 2021-03-31 | 5.70% |
| 2020-12-31 | 6.53% |
| 2020-09-30 | 5.54% |
| 2020-06-30 | 11.19% |
| 2020-03-31 | -27.96% |
| 2019-12-31 | -50.08% |
| 2019-09-30 | -27.10% |
| 2019-06-30 | -26.42% |
| 2019-03-31 | -36.30% |
| 2018-12-31 | -34.28% |
| 2018-09-30 | -11.07% |
| 2018-06-30 | -2.35% |
| 2018-03-31 | -16.91% |
| 2017-12-31 | -110.43% |
| 2017-09-30 | -17.63% |
| 2017-06-30 | -5.58% |
| 2017-03-31 | -10.47% |
| 2016-12-31 | -4.96% |
| 2016-09-30 | -5.03% |
| 2016-06-30 | 4.35% |
| 2016-03-31 | -4.12% |
| 2015-12-31 | 0.58% |
| 2015-09-30 | 89.66% |
| 2015-06-30 | -100.79% |
| 2015-03-31 | -389.28% |
| 2014-12-31 | -207.73% |
| 2014-09-30 | -246.14% |
| 2014-06-30 | -108.22% |
| 2014-03-31 | -200.01% |
| 2013-12-31 | -81.19% |
| 2013-09-30 | -290.67% |
| 2013-06-30 | -14.25% |
| 2013-03-31 | -109.05% |
| 2012-12-31 | -3.37% |
| 2012-09-30 | -81.78% |
| 2012-06-30 | -100.33% |
| 2012-03-31 | -98.11% |
| 2011-12-31 | 317.62% |
| 2011-09-30 | -120.99% |
| 2011-06-30 | -68.18% |
| 2011-03-31 | -82.07% |
| 2010-12-31 | -4.84% |
| 2010-09-30 | -96.78% |
| 2010-06-30 | -83.37% |
| 2010-03-31 | -59.13% |
| 2009-12-31 | -129.84% |
| 2009-09-30 | -423.32% |
| 2009-06-30 | -244.31% |
| 2009-03-31 | -391.00% |
| 2008-12-31 | -577.83% |
| 2008-09-30 | -205.60% |
| 2008-06-30 | -1237.66% |
| 2008-03-31 | -385.27% |
| 2007-12-31 | -1059.98% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | -119016.67% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | -1933.33% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-09-30 | 0.00% |
| 2003-06-30 | 0.00% |
| 2003-03-31 | -7592.31% |
| 2002-12-31 | -67033.33% |
| 2002-09-30 | 0.00% |
